News
Company to Highlight the Role of Precision Diagnostics in Transforming Rare and Undiagnosed Disease CareHOUSTON, Aug. 25, ...
RNA-binding proteins use a dual binding mechanism involving zinc finger (ZnF) domains and intrinsically disordered regions ...
14h
Zacks.com on MSNRNA Stock Moves More Than 30% in a Week: What's Driving This Rally?
Avidity Biosciences surges 36% on reports that Novartis may eye a deal, with talks said to be early and interest from other suitors possible.
The candidates are sourced from Arnatar’s next-gen RNA discovery engine, dubbed DARGER for dual-functional antisense RNA for ...
Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare ...
Messenger RNA, or mRNA – a technology that can instruct cells to fight disease – has fueled breakthroughs from Covid vaccines ...
In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...
A new multi-omics AI model combines cfDNA and cfRNA to predict preterm birth risk with nearly 90% accuracy, offering ...
3d
Amazon S3 on MSNWhat is "endless" RNA?
Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic ...
Both public and private funding have plummeted as federal policy changes have thrown the biotech sector into an era of ...
Sarepta is facing a number of issues currently, including platform-level safety concerns, management credibility issues, etc.
The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results